Brief: Heat Biologics - Effective Feb 1, Engaged Crs Crossroads Strategies To Help In Government Collaborations Related To Co's Covid-19, Other Vaccine Programs
26/01/2021 12:51
Jan 26 (Reuters) - Heat Biologics Inc HTBX.O :
* HEAT BIOLOGICS - EFFECTIVE FEB 1, ENGAGED CRS CROSSROADS
STRATEGIES TO HELP IN GOVERNMENT COLLABORATIONS RELATED TO CO'S
COVID-19, OTHER VACCINE PROGRAMS
Source text for Eikon: [ID:https://bit.ly/3a4ozpE]
Further company coverage: HTBX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scorpius Holdings
See all newsBrief: Scorpius Holdings Inc Files For Non Timely 10-K With U.S. SEC
Brief: Scorpius Holdings Files For Offering Up To 29.4 Million Shares Of Common Stock
Brief: Scorpius Holdings Announces Collaboration With Celltheon Corporation
Brief: Scorpius Holdings - Implementation Of Strategic Cost-Saving Measures Expected To Save Over $2 Mln Annually
Brief: Scorpius Holdings Announces Partnership With U.S. Biotech Company